| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |